ASCENDIS PHARMA A S's ticker is and the CUSIP is 04351P901. A total of 5 filers reported holding ASCENDIS PHARMA A S in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $74,912 | -94.7% | 800 | -95.0% | 0.00% | -100.0% |
| Q2 2023 | $1,419,075 | -75.8% | 15,900 | -71.0% | 0.01% | -76.2% |
| Q1 2023 | $5,875,656 | +96.4% | 54,800 | +123.7% | 0.02% | +200.0% |
| Q4 2022 | $2,992,185 | -31.3% | 24,500 | -41.9% | 0.01% | -22.2% |
| Q3 2022 | $4,358,000 | +1854.3% | 42,200 | +2121.1% | 0.01% | – |
| Q1 2022 | $223,000 | +178.8% | 1,900 | +280.0% | 0.00% | – |
| Q3 2021 | $80,000 | +207.7% | 500 | +150.0% | 0.00% | – |
| Q2 2021 | $26,000 | -50.0% | 200 | -50.0% | 0.00% | – |
| Q1 2021 | $52,000 | -93.4% | 400 | -92.2% | 0.00% | -100.0% |
| Q3 2020 | $787,000 | -26.1% | 5,100 | -29.2% | 0.00% | -60.0% |
| Q2 2020 | $1,065,000 | +4530.4% | 7,200 | +3500.0% | 0.01% | – |
| Q1 2020 | $23,000 | -85.0% | 200 | -81.8% | 0.00% | -100.0% |
| Q4 2019 | $153,000 | +59.4% | 1,100 | +10.0% | 0.00% | 0.0% |
| Q3 2019 | $96,000 | -92.6% | 1,000 | -91.1% | 0.00% | -91.7% |
| Q2 2019 | $1,290,000 | -82.9% | 11,200 | -82.6% | 0.01% | -85.7% |
| Q1 2019 | $7,556,000 | +58023.1% | 64,200 | +32000.0% | 0.08% | – |
| Q4 2018 | $13,000 | -90.4% | 200 | -89.5% | 0.00% | -100.0% |
| Q3 2018 | $135,000 | – | 1,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 54,800 | $5,875,656 | 0.02% |
| SIMPLEX TRADING, LLC | 60,000 | $6,433 | 0.01% |
| JANE STREET GROUP, LLC | 40,700 | $4,363,854 | 0.00% |
| JPMORGAN CHASE & CO | 75,000 | $8,042,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |